Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of AZD9977 in Healthy Japanese Volunteers
NCT03801967Phase 1Completed
- Sponsor
- AstraZeneca
- Start
- Jan 2019
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, single-blind trial in heart failure (HF) comparing AZD9977 with Placebo (2 arms). Primary endpoints: Number of participants with adverse events (AEs), Number of participants with abnormal blood pressure and 5 more. Started Jan 2019; status: completed.
02
Drugs
balcinrenone
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT03801967.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03801967.